Marinus Pharmaceuticals

Marinus Pharmaceuticals Dividend Coverage

Delisted

Dividend Coverage Ratio of Marinus Pharmaceuticals (MRNS) as of Nov 20, 2026.

Dividend Coverage

-

Last updated:

Dividend Coverage Ratio of Marinus Pharmaceuticals is 2026 - . Dividend Coverage Ratio of Marinus Pharmaceuticals was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Marinus Pharmaceuticals Stock analysis

What does Marinus Pharmaceuticals do? Marinus Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the development and commercialization of novel therapeutics for various neurological disorders. The company, headquartered in Radnor, Pennsylvania, USA, was founded in 2003 and has been listed on NASDAQ since 2012. Marinus Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Marinus Pharmaceuticals stock

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Marinus Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Marinus Pharmaceuticals historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Marinus Pharmaceuticals

All Key Metrics — Marinus Pharmaceuticals